Literature DB >> 30601989

Clinical Practice Variation Among Adult Infectious Disease Physicians in the Management of Staphylococcus aureus Bacteremia.

Catherine Liu1,2, Luke Strnad3,4, Susan E Beekmann5,6, Philip M Polgreen5,6, Henry F Chambers7.   

Abstract

Infectious disease management of Staphylococcus aureus bacteremia (SAB) was surveyed through the Emerging Infections Network. Although there were areas of consensus, we found substantial practice variation in diagnostic evaluation and management of adult patients with SAB. These findings highlight opportunities for further research and guidance to define best practices.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Staphylococcus aureus; bacteremia; infectious disease physicians

Mesh：

Substances：

Year:  2019        PMID： 30601989      PMCID： PMC7962895          DOI： 10.1093/cid/ciy1144

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  11 in total

Review 1.  Infectious disease consultation for Staphylococcus aureus bacteremia - A systematic review and meta-analysis.

Authors:  Monique Vogel; Roland P H Schmitz; Stefan Hagel; Mathias W Pletz; Nico Gagelmann; André Scherag; Peter Schlattmann; Frank M Brunkhorst
Journal:  J Infect       Date:  2015-10-09       Impact factor: 6.072

2.  Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study.

Authors:  Kyle P Murray; Jing J Zhao; Susan L Davis; Ravina Kullar; Keith S Kaye; Paul Lephart; Michael J Rybak
Journal:  Clin Infect Dis       Date:  2013-02-28       Impact factor: 9.079

3.  Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database.

Authors:  Andrew F Shorr; Ying P Tabak; Aaron D Killian; Vikas Gupta; Larry Z Liu; Marin H Kollef
Journal:  Crit Care Med       Date:  2006-10       Impact factor: 7.598

4.  Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.

Authors:  Catherine Liu; Arnold Bayer; Sara E Cosgrove; Robert S Daum; Scott K Fridkin; Rachel J Gorwitz; Sheldon L Kaplan; Adolf W Karchmer; Donald P Levine; Barbara E Murray; Michael J Rybak; David A Talan; Henry F Chambers
Journal:  Clin Infect Dis       Date:  2011-01-04       Impact factor: 9.079

Review 5.  Cefazolin versus anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a narrative review.

Authors:  P Loubet; C Burdet; W Vindrios; N Grall; M Wolff; Y Yazdanpanah; A Andremont; X Duval; F-X Lescure
Journal:  Clin Microbiol Infect       Date:  2017-07-08       Impact factor: 8.067

Review 6.  Clinical predictors and clinical prediction rules to estimate initial patient risk for infective endocarditis in Staphylococcus aureus bacteraemia: a systematic review and meta-analysis.

Authors:  Anthony D Bai; Arnav Agarwal; Marilyn Steinberg; Adrienne Showler; Lisa Burry; George A Tomlinson; Chaim M Bell; Andrew M Morris
Journal:  Clin Microbiol Infect       Date:  2017-05-06       Impact factor: 8.067

7.  Clinical Reasoning of Infectious Diseases Physicians Behind the Use or Nonuse of Transesophageal Echocardiography in Staphylococcus aureus Bacteremia.

Authors:  Heather Young; Bryan C Knepper; Connie S Price; Susan Heard; Timothy C Jenkins
Journal:  Open Forum Infect Dis       Date:  2016-09-28       Impact factor: 3.835

8.  A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated study.

Authors:  Shirin Kalimuddin; Yvonne F Z Chan; Rachel Phillips; Siew Pei Ong; Sophia Archuleta; David Chien Lye; Thuan Tong Tan; Jenny G H Low
Journal:  Trials       Date:  2018-06-01       Impact factor: 2.279

9.  The Cefazolin Inoculum Effect Is Associated With Increased Mortality in Methicillin-Susceptible Staphylococcus aureus Bacteremia.

Authors:  William R Miller; Carlos Seas; Lina P Carvajal; Lorena Diaz; Aura M Echeverri; Carolina Ferro; Rafael Rios; Paola Porras; Carlos Luna; Eduardo Gotuzzo; Jose M Munita; Esteban Nannini; Cesar Carcamo; Jinnethe Reyes; Cesar A Arias
Journal:  Open Forum Infect Dis       Date:  2018-05-23       Impact factor: 3.835

Review 10.  The Impact of Infectious Disease Specialist Consultation for Staphylococcus aureus Bloodstream Infections: A Systematic Review.

Authors:  Julie Paulsen; Erik Solligård; Jan Kristian Damås; Andrew DeWan; Bjørn Olav Åsvold; Michael B Bracken
Journal:  Open Forum Infect Dis       Date:  2016-03-01       Impact factor: 3.835
View more
  7 in total

1.  Efficacy of Early Oral Switch with β-Lactams for Low-Risk Staphylococcus aureus Bacteremia.

Authors:  Olivia Bupha-Intr; Tim Blackmore; Max Bloomfield
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

2.  Early Oral Antibiotic Switch for Staphylococcus aureus Bacteremia: Many Are Called, but Few Are Chosen.

Authors:  Thomas L Holland
Journal:  Antimicrob Agents Chemother       Date:  2020-06-23       Impact factor: 5.191

3.  Intermittent Negative Blood Cultures in Staphylococcus aureus Bacteremia; a Retrospective Study of 1071 Episodes.

Authors:  James D Stewart; Maryza Graham; Despina Kotsanas; Ian Woolley; Tony M Korman
Journal:  Open Forum Infect Dis       Date:  2019-11-18       Impact factor: 3.835

4.  Comparing Echocardiographic Modalities in Native-Valve Infective Endocarditis Due to Methicillin-Resistant Staphylococcus Aureus in People Who Inject Drugs.

Authors:  James Livesay; Tyler Coombes; Jared Spoons; Steven Dolacky; Mahmoud Shorman
Journal:  Cureus       Date:  2021-11-08

5.  Clindamycin adjunctive therapy for severe Staphylococcus aureus treatment evaluation (CASSETTE)-an open-labelled pilot randomized controlled trial.

Authors:  A J Campbell; R Dotel; M Braddick; P N Britton; D P Eisen; J R Francis; S Lynar; B McMullan; N Meagher; J Nelson; M V N O'Sullivan; D J Price; J O Robinson; A Whelan; S Y C Tong; A C Bowen; J S Davis
Journal:  JAC Antimicrob Resist       Date:  2022-02-17

6.  Economic Analysis of Infectious Disease Consultation for Staphylococcus aureus Bacteremia Among Hospitalized Patients.

Authors:  Elina Eleftheria Pliakos; Panayiotis D Ziakas; Eleftherios Mylonakis
Journal:  JAMA Netw Open       Date:  2022-09-01

7.  Management of Staphylococcus aureus bacteraemia (SAB) in the oncology patient: Further evidence supports prompt removal of central venous catheters and shorter duration of intravenous antimicrobial therapy.

Authors:  Colum P Dunne; Phelim Ryan; Roisin Connolly; Suzanne S Dunne; Mohammed A Kaballo; James Powell; Bernie Woulfe; Nuala H O'Connell; Rajnish K Gupta
Journal:  Infect Prev Pract       Date:  2020-02-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.